• G20210A mutation in the Prothrombin (Factor II) gene
  • Second most common
  • Variant is a point mutation in which adenine is substituted for guanine at position 20210 in F2 gene
  • Mechanism incompletely understood
    • Though secondary to increased concentration ad possibility efficiency of prothrombin
  • Diagnosis
    • Genetic test
  • Treatment similar to Factor V Leiden
    • Asymptomatic - nil
    • Symptomatic - as per normal Deep vein thrombosis.
      • Individualize the duration of аոtiϲοаgսlаtion according to features such as whether the VΤЕ was provoked, life-threatening, or at an unusual site, as done for the general population, rather than a more aggressive approach.